NESA Acupuncture Research Collaborative

作为补充和替代医学(DCRC)研究的发展中心，新英格兰 针灸学院(NESA)-哈佛针灸研究协作组将汇集来自 东方医学(OM)和传统医学界对其疗效和安全性进行严格评估 针灸，并制定针灸研究所需的合理方法和可行的研究设计。我们的 DCRC将加强和发展Nesa、哈佛医学院和Nesa之间的合作 (HMS)Osher研究所，以及另外两个HMS附属机构，Dana Farber癌症研究所和儿童 波士顿医院。刚果民主共和国将支持三项发展/探索性研究和两项基础设施核心。 (行政和临床试验)，这将由三个主题协同整合。第一个主题以 围绕使OM研究多样化，以评估临床实践中采用的多种方法，这将是 通过对日式针灸和中国式针灸的评价来解决。第二个主题强调 开发和实施新的研究方法，以应对 针灸和OM的临床试验。我们三项研究中的一项将开发、验证和测试 在临床试验中用于得出OM诊断的仪器。与以下内容相关的其他方法学问题 针灸治疗的个体化、针灸试验中的适当对照以及结果的发展 还将讨论反映OM治疗理念的措施。第三个主题阐述了 针灸作为治疗女性健康状况的辅助疗法。具体来说，我们会研究 针灸在目前评价其疗效和安全性的两种情况下的应用 卵巢癌患者化疗引起的中性粒细胞减少，青少年和女性慢性盆腔疼痛 患有子宫内膜异位症的年轻女性。我们的DCRC不可或缺的是一些学术和行政指导 HMS教职员工和培训计划将通过这些计划帮助NESA发展其临床研究 基础设施和自主维持结合最高标准的生产性研究计划的能力 科学和传统OM实践的完整性。我们DCRC的最终目标将是让Nesa发挥 在未来提交建立在我们发展研究基础上的R01和R21提案方面发挥主导作用。

As a Developmental Center for Research in Complementary and Alternative Medicine (DCRC), the New England School of Acupuncture (NESA)-Harvard Acupuncture Research Collaborative will bring together leaders from the oriental medicine (OM) and conventional medicine communities to critically evaluate the efficacy and safety of acupuncture, and develop sound methodologies and feasible study designs required for acupuncture research. Our DCRC will strengthen and build upon already ongoing collaborations between NESA, the Harvard Medical School's (HMS) Osher Institute, and two other HMS-affiliated institutions, the Dana Farber Cancer Institute and Children's Hospital Boston. The DCRC will support three developmental/exploratory studies and two infrastructure cores (Administrative and Clinical Trials) that will be synergistically integrated by three themes. The first theme centers around diversifying OM research to evaluate the plurality of approaches employed in clinical practice which will be addressed through the evaluation of both Japanese- and Chinese-style acupuncture. The second theme emphasizes the development and implementation of novel research methods that are required to meet the unique challenges posed in clinical trials of acupuncture and OM. One of our three studies will develop, validate, and test the reliability of an instrument used to derive OM diagnoses in the context of clinical trials. Other methodological issues related to individualization of acupuncture treatments, appropriate controls in acupuncture trials, and the development of outcome measures that reflect the treatment philosophy of OM will also be addressed. The third theme addresses the benefits of acupuncture as an adjunct therapy in the treatment of women's health conditions. Specifically, we will study the application of acupuncture to two conditions for which the current evidence evaluating its efficacy and safety is limited-- chemotherapy-induced neutropenia in women with ovarian cancer, and chronic pelvic pain in adolescent and young women with endometriosis. Integral to our DCRC are a number of academic and administrative mentoring programs through which HMS faculty, staff, and training programs will assist NESA in developing its clinical research infrastructure and capacity to autonomously sustain a productive research program that combines the highest standards of science and the integrity of traditional OM practices. The ultimate goal of our DCRC will be for NESA to play the lead role in the future submission of R01 and R21 proposals that build upon our developmental studies.